Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Repatha 140 mg solution for injection in pre-filled pen
DRUG
2 trials
Sponsors
Assistance Publique Hopitaux De Paris
, Centre Hospitalier Universitaire Grenoble Alpes
Conditions
acute myocardial infarction
atherosclerotic cardiovascular disease
Phase 2
Effect of impact of PCSK9 inhibitor on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular disease needing coronarography.
Active, not recruiting
CTIS2024-519012-14-00
Centre Hospitalier Universitaire Grenoble Alpes
atherosclerotic cardiovascular disease
Start: 2020-09-15
Target: 66
Updated: 2024-11-15
Phase 4
AMUNDSEN - Acute Myocardial infarction Upbound to percutaneous coronary intervention, immediately (STEMI) or in the Next three Days (NSTEMI), and randomized to Subcutaneous Evolocumab or Normal strategies to reach guidelines LDL objectives in the real-world - The AMUNDSEN-real trial-
Recruiting
CTIS2024-518195-31-00
Assistance Publique Hopitaux De Paris
acute myocardial infarction
Start: 2021-09-29
Target: 2166
Updated: 2025-12-05
Related Papers
Evolocumab before percutaneous coronary intervention for acute myocardial infarction: Design of the AMUNDSEN trial.
2025-11-03